Showing results (2311-2320 of 3,014) with videos related to

Sort By:
Pageof 302
American Journal of Preventive Medicine|September 21, 2016
Community-wide Interventions to Prevent Skin Cancer: Two Community Guide Systematic ReviewsParamjit K Sandhu, Randy Elder, Mona Patel, et al.
Cytometry|January 1, 1991
Precision of DNA flow cytometry in inter-institutional analysesL L Wheeless, J S Coon, C Cox, et al.
Journal of Wildlife Diseases|May 24, 2014
Nonlethal screening of bat-wing skin with the use of ultraviolet fluorescence to detect lesions indicative of white-nose syndromeGregory G Turner, Carol Uphoff Meteyer, Hazel Barton, et al.
BMC Cancer|March 27, 2023
Oncological healthcare providers' perspectives on appropriate melanoma survivorship care: a qualitative focus group studyNadia C W Kamminga, Marlies Wakkee, Rianne J De Bruin, et al.
Resuscitation|November 9, 2025
Severe intracranial hemorrhage or ischemia associated with unfavorable outcomes after pediatric in-hospital cardiac arrestNatalie L Ullman, Ron W Reeder, Alexis Topjian, et al.
JCO Oncology Practice|June 9, 2023
Knowledge, Attitudes, and Resources of Frontline Oncology Support Personnel Regarding Financial Burden in Patients With CancerKatherine E Reeder-Hayes, Caitlin B Biddell, Michelle L Manning, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|February 11, 2017
Characteristics and outcomes of re-do percutaneous paravalvular leak closureMohammed A Al-Hijji, Mohamad Alkhouli, Mohammad Sarraf, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|July 10, 2021
Clinical predictors and impact of postoperative mean gradient on outcome after transcatheter edge-to-edge mitral valve repairDidem Oguz, Ratnasari Padang, Sorin V Pislaru, et al.
Journal of Hematology & Oncology|November 4, 2017
Observational study of lenalidomide in patients with mantle cell lymphoma who relapsed/progressed after or were refractory/intolerant to ibrutinib (MCL-004)Michael Wang, Stephen J Schuster, Tycel Phillips, et al.
Pageof 302